The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics FDA takes first step in possible reversal of ban on some peptides The Washington Post The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Peptide and Lyme Disease: Tissue Repair and Immune Support FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks